Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
56,940published records in database
4recall categories represented
Jun 28, 2023newest stored source record
Latest records
Latest recalls — page 550
The newest recall records with useful source details are listed here.
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Complaints on clip deployment occurring during clinical procedures, leading to hazardous situations where clips fail to achieve their expected function or deploy incorrectly, potentially…
Class IIFDA: OngoingOlympus Corporation of the Americas
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Plastic sterilization trays used to encase and protect medical devices during sterilization have a new 510(k) with instructions for use that is for the first time specific to the tray…
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.